🚀 VC round data is live in beta, check it out!
WELL Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for WELL Health and similar public comparables like AMN Healthcare Services, Nutex Health, Diagnósticos da América, Spire Healthcare Group and more.
WELL Health Overview
About WELL Health
WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth. WELL Health USA Patient Services includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing and SaaS and Technology Services. It generates the majority of its revenue from Well Health USA Patient and Provider Services unit.
Founded
2010
HQ
Employees
3.2K
Website
Sectors
Financials (LTM)
EV
$1B
WELL Health Financials
WELL Health reported last 12-month revenue of $1B and EBITDA of $143M.
In the same LTM period, WELL Health generated $463M in gross profit, $143M in EBITDA, and had net loss of ($4M).
Revenue (LTM)
WELL Health P&L
In the most recent fiscal year, WELL Health reported revenue of $1B and EBITDA of $148M.
WELL Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $463M | XXX | $452M | XXX | XXX | XXX |
| Gross Margin | 44% | XXX | 44% | XXX | XXX | XXX |
| EBITDA | $143M | XXX | $148M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 15% | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | 7% | XXX | XXX | XXX |
| Net Profit | ($4M) | XXX | ($5M) | XXX | XXX | XXX |
| Net Margin | (0%) | XXX | (1%) | XXX | XXX | XXX |
| Net Debt | — | — | $275M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
WELL Health Stock Performance
WELL Health has current market cap of $766M, and enterprise value of $1B.
Market Cap Evolution
WELL Health's stock price is $3.00.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $766M | 1.0% | XXX | XXX | XXX | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialWELL Health Valuation Multiples
WELL Health trades at 1.0x EV/Revenue multiple, and 7.7x EV/EBITDA.
EV / Revenue (LTM)
WELL Health Financial Valuation Multiples
As of April 18, 2026, WELL Health has market cap of $766M and EV of $1B.
Equity research analysts estimate WELL Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
WELL Health has a P/E ratio of (198.2x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $766M | XXX | $766M | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 7.7x | XXX | 7.5x | XXX | XXX | XXX |
| EV/EBIT | 20.9x | XXX | 16.4x | XXX | XXX | XXX |
| EV/Gross Profit | 2.4x | XXX | 2.5x | XXX | XXX | XXX |
| P/E | (198.2x) | XXX | (142.7x) | XXX | XXX | XXX |
| EV/FCF | 23.0x | XXX | 16.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified WELL Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
WELL Health Margins & Growth Rates
WELL Health's revenue in the last 12 month grew by 10%.
WELL Health's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
WELL Health's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
WELL Health's rule of X is 41% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
WELL Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | (6%) | XXX | (12%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 23% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 41% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 7% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 30% | XXX | 29% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 38% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
WELL Health Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| WELL Health | XXX | XXX | XXX | XXX | XXX | XXX |
| AMN Healthcare Services | XXX | XXX | XXX | XXX | XXX | XXX |
| Nutex Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Diagnósticos da América | XXX | XXX | XXX | XXX | XXX | XXX |
| Spire Healthcare Group | XXX | XXX | XXX | XXX | XXX | XXX |
| HCG Hospitals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
WELL Health M&A Activity
WELL Health acquired XXX companies to date.
Last acquisition by WELL Health was on XXXXXXXX, XXXXX. WELL Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by WELL Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialWELL Health Investment Activity
WELL Health invested in XXX companies to date.
WELL Health made its latest investment on XXXXXXXX, XXXXX. WELL Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by WELL Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout WELL Health
| When was WELL Health founded? | WELL Health was founded in 2010. |
| Where is WELL Health headquartered? | WELL Health is headquartered in Canada. |
| How many employees does WELL Health have? | As of today, WELL Health has over 3K employees. |
| Who is the CEO of WELL Health? | WELL Health's CEO is Hamed Shahbazi. |
| Is WELL Health publicly listed? | Yes, WELL Health is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of WELL Health? | WELL Health trades under WELL ticker. |
| When did WELL Health go public? | WELL Health went public in 2012. |
| Who are competitors of WELL Health? | WELL Health main competitors are AMN Healthcare Services, Nutex Health, Diagnósticos da América, Spire Healthcare Group. |
| What is the current market cap of WELL Health? | WELL Health's current market cap is $766M. |
| What is the current revenue of WELL Health? | WELL Health's last 12 months revenue is $1B. |
| What is the current revenue growth of WELL Health? | WELL Health revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of WELL Health? | Current revenue multiple of WELL Health is 1.0x. |
| Is WELL Health profitable? | Yes, WELL Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of WELL Health? | WELL Health's last 12 months EBITDA is $143M. |
| What is WELL Health's EBITDA margin? | WELL Health's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of WELL Health? | Current EBITDA multiple of WELL Health is 7.7x. |
| What is the current FCF of WELL Health? | WELL Health's last 12 months FCF is $48M. |
| What is WELL Health's FCF margin? | WELL Health's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of WELL Health? | Current FCF multiple of WELL Health is 23.0x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.